Trial Profile
A Randomized Double-Blind, Double-Dummy, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-438 20mg Compared to Lansoprazole 30mg Once- or Twice-Daily in the Treatment of Endoscopically Confirmed Gastric Ulcer Subjects With or Without Helicobacter Pylori Infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Lansoprazole
- Indications Gastric ulcer
- Focus Therapeutic Use
- Sponsors Takeda
- 02 Jun 2020 Status changed from active, no longer recruiting to completed.
- 25 Mar 2020 Planned End Date changed from 18 Mar 2020 to 31 May 2020.
- 12 Mar 2020 Planned End Date changed from 24 Mar 2020 to 18 Mar 2020.